Specifically, the CD34+ median expression levels were 0.390 (IQR 0.120–0.500) in MS group and 0.210 (IQR 0.170–0.240) in CTRL group (p = 0.203), whereas the CD133+ median expression levels were 0.240 (IQR 0.090–0.400) in the MS group and 0.120 (IQR 0.110–0.160) in the CTRL group. The gene discussed is CD34; the disease is myeloid sarcoma.